Furthermore, we developed a novel CBC-based prognostic score, called the CBCS, based on the combination of the LMR and Hb level after dichotomization to more accurately and easily predict the long-term prognosis of GC patients. The gene discussed is GSTM1; the disease is gastric cancer.